2016 International Congress Archives - Page 172 of 207

Staging and clinical correlates of cortical thinning in Parkinson’s disease

H. Wilson, F. Niccolini, C. Pellicano, P. Piccini, M. Politis (London, United Kingdom)
Staging of cognitive impairment: Validation of a novel cognitive score with [¹⁸F]FDG-PET

D. Blum, M. Reimold, W. Maetzler, C. la Fougère, G. Reischl, D. Berg, I. Liepelt-Scarfone (Tübingen, Germany)
Standardized assessment of camptocormia in idiopathic Parkinson’s disease

T. Schmidt, G. Ebersbach, G. Doreen (Beelitz-Heilstätten, Germany)
Statistical aspects when exploring the association between change in body mass index (BMI), UPDRS scores and survival in the NET PD long-term study-1

A. Perez, A.M. Wills, J. Wang, X. Su, J. Morgan, S.S. Rajan, M. Leehey, G.M. Pontone, K.L. Chou, C. Umeh, Z. Mari, J. Boyd, For the NINDS NET-PD Investigators (Austin, TX, USA)
Status of NPF-QII after six years: Updates to the dataset

F. Cubillos, E.C. Nelson, T. Simuni, C. Marras, M. Rafferty, T. Davis, P. Schmidt (Miami, FL, USA)
STEADY-PD III. A phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson’s disease. Baseline characteristics of the enrolled cohort

T. Simuni, K.M. Biglan, J. Lowell, K. Hodgeman, B. Greco, R. Rockhill, D. Oakes (Chicago, IL, USA)
Stereotactic pallidotomy for Parkinson’s disease in El Salvador: One year follow up

S.L. Peña, R.E. Amaya (San Salvador, El Salvador)
Stereotactic surgery targeting on ventral oral posterior/ventral intermediate (Vop/Vim) in patients with upper limb dystonia: Neuronal activity and optimal effective site

N. Murase, M. Matsuhashi, K. Maeda, S. Kawarazaki, M. Nakamura, T. Thukahara, H. Hirabayashi (Kyoto City, Japan)
Stiff person syndrome

P. Dosekova, G. Krastev, J. Haring, R. Lackovic (Trnava, Slovakia (Slovak Republic))
Stiff person syndrome: Case series

E. Sasse, G. Amorelli, M. Spitz, C.S.B. Germano, L.F. Vasconcellos (Rio De Janeiro, Brazil)